No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Treace to Report First Quarter 2025 Financial Results on May 8, 2025
BTIG Maintains Treace Medical Concepts(TMCI.US) With Buy Rating, Cuts Target Price to $14
BTIG Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Cuts Target Price to $8
Truist Cuts Price Target on Treace Medical Concepts to $8 From $9.50, Keeps Hold Rating
Is Treace Medical Concepts (NASDAQ:TMCI) Weighed On By Its Debt Load?